Decreased directed functional connectivity in the psychedelic state by Barnett, Lionel et al.
Decreased directed functional connectivity in the psychedelic 
state
Article  (Published Version)
http://sro.sussex.ac.uk
Barnett, Lionel, Muthukumaraswamy, Suresh D, Carhart-Harris, Robin L and Seth, Anil K (2019) 
Decreased directed functional connectivity in the psychedelic state. NeuroImage, 209. a116462. 
ISSN 1053-8119 
This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/88727/
This document is made available in accordance with publisher policies and may differ from the 
published  version or from the version of record. If you wish to cite this item you are advised to 
consult the publisher’s version. Please see the URL above for details on accessing the published 
version. 
Copyright and reuse: 
Sussex Research Online is a digital repository of the research output of the University.
Copyright and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable, the material 
made available in SRO has been checked for eligibility before being made available. 
Copies of full text items generally can be reproduced, displayed or performed and given to third 
parties in any format or medium for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge, provided that the authors, title and full bibliographic 
details are credited, a hyperlink and/or URL is given for the original metadata page and the 
content is not changed in any way. 
NeuroImage 209 (2020) 116462Contents lists available at ScienceDirect
NeuroImage
journal homepage: www.elsevier.com/locate/neuroimageDecreased directed functional connectivity in the psychedelic state
Lionel Barnett a,*, Suresh D. Muthukumaraswamy b, Robin L. Carhart-Harris c, Anil K. Seth a
a Sackler Centre for Consciousness Science and Department of Informatics, University of Sussex, Falmer, Brighton, BN1 9QJ, UK
b School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, 1142, New Zealand
c Centre for Psychedelic Research, Department of Medicine, Imperial College London, London, SW7 2AZ, UKA R T I C L E I N F O
Keywords:
Psychedelic state
Granger causality
Information flow
Neural dynamics* Corresponding author.
E-mail addresses: l.c.barnett@sussex.ac.uk (L. B
Harris), a.k.seth@sussex.ac.uk (A.K. Seth).
1 There is no universally agreed-on definition for
serotonergic psychedelics and glutamatergic dissoc
https://doi.org/10.1016/j.neuroimage.2019.11646
Received 15 July 2019; Received in revised form 8
Available online 17 December 2019
1053-8119/© 2019 The Authors. Published by Else
nc-nd/4.0/).A B S T R A C T
Neuroimaging studies of the psychedelic state offer a unique window onto the neural basis of conscious
perception and selfhood. Despite well understood pharmacological mechanisms of action, the large-scale changes
in neural dynamics induced by psychedelic compounds remain poorly understood. Using source-localised, steady-
state MEG recordings, we describe changes in functional connectivity following the controlled administration of
LSD, psilocybin and low-dose ketamine, as well as, for comparison, the (non-psychedelic) anticonvulsant drug
tiagabine. We compare both undirected and directed measures of functional connectivity between placebo and
drug conditions. We observe a general decrease in directed functional connectivity for all three psychedelics, as
measured by Granger causality, throughout the brain. These data support the view that the psychedelic state
involves a breakdown in patterns of functional organisation or information flow in the brain. In the case of LSD,
the decrease in directed functional connectivity is coupled with an increase in undirected functional connectivity,
which we measure using correlation and coherence. This surprising opposite movement of directed and undi-
rected measures is of more general interest for functional connectivity analyses, which we interpret using
analytical modelling. Overall, our results uncover the neural dynamics of information flow in the psychedelic
state, and highlight the importance of comparing multiple measures of functional connectivity when analysing
time-resolved neuroimaging data.1. Introduction
Psychedelic drugs1 impact profoundly on conscious experiences of
world and self, providing a unique opportunity to examine the neural and
cognitive bases of these subjective phenomena. The classical psyche-
delics, notably LSD and psilocybin, have complex mixed mechanisms of
action, binding to several targets in the brain. However, multiple studies
have demonstrated that the psychedelic effects of LSD/psilocybin are
predominantly driven by partial agonist actions at the serotonin 2A re-
ceptor (5HT2AR) (Preller et al., 2018; Quednow et al., 2012). Biased
agonism at the 5HT2AR for LSD/psilocybin compared to endogenous
serotonin triggers different second-messenger pathways, which enhance
release of the excitatory neurotransmitter glutamate (Nichols, 2016).
Ketamine—which at low (sub-anesthetic) doses has psychedelic-like
properties—also has a complex mixed pharmacology, but at sub-
anaesthetic doses its primary mechanism of action is thought to be as anarnett), sd.muthu@auckland.ac.
what constitutes a psychedelic dru
iatives such as ketamine/PCP.
2
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vier Inc. This is an open access arNMDA receptor antagonist (Sleigh et al., 2014). Blockade of NMDA re-
ceptors on inhibitory neurons can cause reduced gain control of these
neurons, increasing glutamate release by pyramidal cells (Krystal et al.,
2013). Ketamine and the classical psychedelics have distinct associated
subjective phenomena. Broadly speaking, ketamine creates a more
dissociative bodily experience with spatiotemporal distortions, while
classical psychedelics cause greater alterations of sensory experiences
(particularly in the visual domain) as well as mystical experiences (see
Vollenweider and Kometer, 2010). Many studies now link the subjective
effects of psychedelics to altered activity at the relevant receptors (Preller
et al., 2018; Deco et al., 2018). However, despite these links, the
large-scale changes in neural dynamics that underlie the dramatic sub-
jective effects of psychedelics remain poorly understood.
One window onto large-scale neural dynamics is to measure func-
tional connectivity (FC). FC between brain regions refers to the existence
of statistical dependencies in their activity (Seth et al., 2015). Severalnz (S.D. Muthukumaraswamy), r.carhart-harris@imperial.ac.uk (R.L. Carhart-
g. Here we use the term “psychedelics” in a broad sense to include both classical
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data obtained from healthy volunteers under either psilocybin or LSD.
These studies have revealed a reorganisation of connectivity within and
between resting-state networks, generally showing decreased connec-
tivity within resting-state networks and increased connectivity across
such networks (Carhart-Harris et al., 2012, 2016; Tagliazucchi et al.,
2016; Müller et al., 2017, 2018; Kaelen et al., 2016), see also Preller et al.
(2018). For example, decreased connectivity within the default-mode
network has been associated with subjective ego dissolution (Smi-
gielski et al., 2019), as has increased connectivity across normally
functionally segregated networks (Tagliazucchi et al., 2016).
Despite the insights provided by these studies there are inherent
limitations on FC analysis of fMRI data imposed by the poor temporal
resolution of such data, induced both by low sampling frequencies and
the slow dynamics of the hemodynamic response. More fine-grained FC
analysis is possible when analysing high-time resolution electrophysio-
logical data, as can be obtained using EEG or MEG. Importantly, because
of the high temporal resolution (as compared with fMRI), such data are
particularly suitable for measuring and comparing undirected and directed
measures of FC. MEG, in particular, is highly suitable for such analysis
since unlike EEG it is not subject to confounds arising through volume
conduction in the skull.
The distinction between directed and undirected FC is critical in
providing a comprehensive picture of statistical dependencies between
regional brain activities. Undirected measures, like correlation and
coherence, are symmetric by definition. These measures can be thought
of as reflecting “shared information” between variables, with mutual
information being the most general case. Directed measures, such as
Granger causality (GC), are generally not symmetric; these measures
reflect “information flow” between variables, with transfer entropy
(Schreiber, 2000; Palus et al., 2001) being the most general case (Barnett
et al., 2009; Barnett and Bossomaier, 2013). Note that both are distinct
from measures of “effective connectivity (EC)” [for example, dynamic
causal modelling (DCM, Friston et al., 2013)] which aim to describe the
minimal causal circuit capable of reproducing some observed dynamics
[see Muthukumaraswamy et al. (2015a) for an application of DCM to
brain dynamics under ketamine]. Functional connectivity metrics,
whether directed or undirected, describe relationships between dynam-
ical variables of a system, whereas effective connectivity uses dynamics
to make inferences about the underlying mechanisms in a system (Seth
et al., 2015; Barnett et al., 2009; Barnett and Seth, 2014; Friston et al.,
2013).
A few studies have applied fine-grained FC analyses to neuroimaging
data obtained in the investigations of the psychedelic state. In an EEG
study, Kometer et al. (2015) report increased (undirected) phase syn-
chronisation under psilocybin. Using MEG, Rivolta et al. (2015) find
increased (directed) transfer entropy in thalamocortical networks under
low-dose ketamine. Transfer entropy has also been applied to EEG data
obtained under ayahuasca (another serotonergic psychedelic), revealing
alterations in anterior-to-posterior and posterior-to-anterior information
flow (Alonso et al., 2015). In an EEG study on the functional effects of
sub-anesthetic ketamine, Vlisides et al. (2017) report (undirected) theta
phase locking between anterior and posterior regions as measured by the
weighted phase lag index, along with reduced anterior-to-posterior
directed connectivity as measured by the directed phase lag index
(Stam and van Straaten, 2012). However, a comprehensive picture of
how directed and undirected FC change together, under a range of psy-
chedelics, and compared against non-psychedelic controls, is still lacking.
We therefore set out to characterise the large-scale alterations in FC in
the psychedelic state by analysing source-localised MEG data, using both
directed and undirected FC measures on the same data, and comparing a
range of psychedelics as well as a non-psychedelic control. These data
had been previously obtained from healthy volunteers following
administration of LSD, psilocybin, or ketamine. We compared these to
data following the administration of tiagabine as an additional non-2psychedelic comparator condition. Tiagabine is a non-psychedelic
GABA reuptake inhibitor which is clinically employed as an anticon-
vulsant (Cosford et al., 1998; Johannessen, 2004).
MEGwas carried out on healthy volunteers in a non-task resting state,
and each volunteer underwent a separate placebo session (see Section 2.1
below), as well as a drug session. We measured both undirected FC
(correlation in the time domain, coherence in the frequency domain) and
directed FC (Granger causality, in both time and frequency domains) on
the same data. Our analyses were, where possible, fully conditional to
control for indirect influences, which can affect inferences about FC in
multivariate systems. Our primary question was whether the psyche-
delics would elicit reliable changes in directed and undirected FC be-
tween and within cortical regions, as compared with placebo, and as
compared with the non-psychedelic drug (tiagabine) control. All analyses
were treated as exploratory.
Note that there are two levels of control in our analysis. Firstly, for
each drug, (non-psychoactive) placebo acts as a control to the psycho-
active drug condition on a per-subject level; that is, for a given drug,
functional connectivity changes are measured, per subject, relative to
placebo. Secondly, tiagabine stands as a “psychedelic vs. non-psyche-
delic” comparator: while psychotropic, its effect is non-psychedelic.
Anticipating results, we find a decrease in directed FC generally be-
tween brain regions, for all psychedelic compounds, but not for tiagabine
(control). In some instances these decreases are accompanied by in-
creases in undirected FC. We interpret these results as suggesting
decreased neural information flow in the psychedelic state, consistent
with perspectives that emphasise increasing disorder and functional
disorganisation underlying the psychedelic experience (Carhart-Harris
et al., 2012; Carhart-Harris, 2018; Carhart-Harris and Friston, 2019;
Schartner et al., 2017).
2. Materials and methods
2.1. Participants and drug delivery
The experiments for resting-state pharmaco-MEG recordings of LSD,
psilocybin (PSI), ketamine (KET) and tiagabine (TGB) used in this article
have all previously been analysed in published studies. Full acquisition
details are given in Carhart-Harris et al. (2016) [LSD], Muthukumar-
aswamy et al. (2013) [PSI], Muthukumaraswamy et al. (2015b) [KET],
and Nutt et al. (2015) [TGB], however, a brief overview is provided here.
Briefly, participants were excluded if they were younger than 21, preg-
nant, had personal or immediate family history of psychiatric disorder,
suffered from substance dependence, had cardiovascular disease, suf-
fered from claustrophobia, blood or needle phobia, or if they had a
medically significant condition rendering them unsuitable for study
participation. For LSD and PSI participants must have had previous
experience with a hallucinogenic drug, but not within 6 weeks of the
study. For KET, participants were additionally excluded if they smoked,
were female, or had a body-mass index outside the range of 18 30. LSD
and PSI were each administered intravenously at a fixed single dose of 75
μg and 2 mg, respectively, over the course of less than 1 min. By contrast
KET was administered with an initial bolus of 0.25 mg/kg delivered over
1 min, followed by maintenance infusion at a rate of 0.375 mg/kg/h for
40 min. PSI and KET data were obtained immediately after drug
administration, whereas for LSD the data were obtained 4 h after drug
administration, due to LSD’s slow pharmacodynamics. For TGB, 15 mg of
tigabine (Gabitril®) was administered orally with recordings made 3 h
after ingestion – near the estimated pharmacokinetic peak of tiagabine.
Overall, data acquisition was timed to coincide as far as possible with
peak subjective effect. Placebos were saline solution for intravenous
drugs (PSI, LSD, KET) and identical inactive capsules for TGB; placebo
trials were conducted with identical procedures, and under identical
conditions to the corresponding drug.
Table 1
Large anatomical regions (ROIs).
Label Name AAL sources
Cin Cingulate 31–36
Fro Frontal 3-16, 19-28
Lim Limbic 37–42
Occ Occipital 43–56
Par Parietal 59–70
Sen Sensorimotor 1-2,17–18,57-58
Sub Subcortical 71–78
Tem Temporal 29-30,79-90
Table 2
Number of epochs per drug by subject, after removal of artefacted epochs.
Number in brackets is number of subjects per drug. Left-hand columns: placebo
epochs per subject, right-hand columns: drug epochs per subject.
LSD (15) Psilocybin (14) Ketamine (19) Tiagabine (15)
201 193 137 150 298 277 148 144
208 205 144 99 277 295 146 147
209 209 148 115 280 277 148 144
192 161 135 145 256 267 133 104
76 207 149 149 295 287 135 140
207 196 145 135 261 261 138 122
204 204 127 139 282 286 148 144
202 207 146 84 290 293 147 139
201 207 126 82 288 281 138 114
210 210 146 143 281 187 136 147
194 196 150 150 292 268 119 140
210 208 123 86 291 298 144 148
206 208 142 79 289 291 118 150
205 201 145 135 287 196 139 130
208 209 275 256 150 142
270 208
250 269
269 265
283 295
Table 3
Standardised frequency bands. Frequencies above
100Hz are omitted from γh as they are possibly
compromised by roll-off from 100Hz low-pass filter,
and in any case were not considered functionally
relevant.
Band Frequency range (Hz)
δ 1 4
θ 4 8
α 8 15
β 15 30
γl 30 50
γh 50 100
L. Barnett et al. NeuroImage 209 (2020) 1164622.2. Experimental procedure, data acquisition and preprocessing
All MEG data were collected using the CTF 275-channel axial gradi-
ometer system housed at the Cardiff University Brain Research Imaging
Centre (CUBRIC) from 2011 to 2014. Participants lay in a supine position
for KET and LSD but were seated for PSI and TGB. All analyses are based
on resting-state recordings post-administration of drug and placebo. The
recording length varied by drug (7 14 min for LSD, 5min for PSI and
TGB, and 10min for KET). Originally sampled at 600Hz or 1200Hz
(depending on the study), the data was high-pass filtered at 1Hz to
suppress slow transients, low-pass filtered at 150Hz, and downsampled
to 300Hz (Barnett and Seth, 2011)2. Line noise was suppressed by sub-
tracting a least-squares-fit sinusoidal signal at 50Hz and harmonics. The
MEG time series were segmented into 2s epochs comprising 600Hz  2s
¼ 1200 observations, and visual inspection used to remove epochs with
artefacts. The number of usable epochs thus varies with drug, subject and
condition (i.e., drug or placebo); numbers are given in Table 2. The MEG
data were source-localised to 90 cortical regions using the centroid lo-
cations of the standard Automated Anatomical Labelling (AAL) brain
atlas (Tzourio-Mazoyer et al., 2002), similar to previous published works
(Pang et al., 2016; Hillebrand et al., 2016; Hunt et al., 2016; Koelewijn
et al., 2019). Source localisation was performed using a linearly con-
strained minimum variance beamformer with 5% regularisation of
broadband sensor covariance matrices (Van Veen et al., 1997). For some
analyses, the 90 AAL regions were grouped into the larger anatomical2 We assume frequencies above 150Hz are not biophysically relevant. In
addition, downsampling improves some functional connectivity measurements
(Barnett and Seth, 2017).
3regions listed in Table 1. We refer to the AAL regions as “sources”, and
the larger regions in Table 1 as “ROIs”. We recognise that not all AAL
sources are likely to contribute significantly to functional connectivity
changes associated with the various drugs. However, in case the MEG
signal from a particular source does not co-vary systematically with the
signals from other “pertinent” sources between the drug and placebo
conditions, this will not introduce bias into our statistics (although sta-
tistical power may be impacted). Rather than preempt potential effects,
we thus include all 90 AAL sources in our analysis.
Epochs are analysed as stationary multi-trial (also known as “panel”)
data in source space: the assumption is that all 2s epochs for a given
drug/subject/condition are realisations of the same underlying stochastic
process, and may therefore be pooled for statistical estimation. Although
this assumption is difficult to validate rigorously, in the present case
treating the data as multi-trial yielded stable autoregressive models
(Appendix A.2), indicating consistent statistical properties across epochs.
It is also a reasonable assumption given the relatively short length of the
MEG recordings relative to the duration of the subjective drug effects,
which reliably extended long beyond the recording periods. With the
exception of spectral power estimation, epochs were normalised per
drug/subject/condition by the pooled mean and variance.32.3. Functional connectivity analysis
We applied both directed and undirected measures of functional
connectivity. In the time domain we measured correlation (undirected)
and Granger causality (directed). In the frequency domain we measured
coherence (undirected) and spectral Granger causality (directed). These
statistics all have information-theoretic interpretations which are exact if
the data are Gaussian (Barnett et al., 2009), and asymptotic otherwise
(Barnett and Bossomaier, 2013). (The marginal distributions of the
normalised MEG data are, in our case, approximately Gaussian.) Corre-
lation equates to mutual information (Cover and Thomas, 1991), a
measure of undirected shared information, while Granger causality
equates to transfer entropy (Schreiber, 2000; Palus et al., 2001), a
measure of the rate of directed information flow between stochastic
processes.
In multivariate situations, measures of FC can be confounded by in-
direct associations. That is, a variable Amay appear to be correlated with
(or to Granger-cause) a variable B when only A and B are measured, but
may be revealed to be unrelated when a third (common influence) var-
iable C is also included in the analysis. Therefore, where appropriate, we
used conditional (or “partial”) FC measures, which control for indirect
associations. (Note that it is not possible to control for indirect associa-
tions mediated by latent/unrecorded common influences, although their
presence may potentially be inferred; cf. Section 4.) Conditioning in a3 For linear modelling of multi-trial data, epochs should not be normalised
individually by per-epoch mean and variance, as this will introduce avoidable
bias in model estimation; this follows from the Gauss-Markov Theorem (Greene,
2012).
Fig. 1. Change in spectral power by source and frequency band. Spectral estimates are based on a multi-taper method averaged over epochs (Section 3.2). In this and
subsequent figures, colour indicates cross-subject effect size (rank correlation; see Section 2.4): red indicates an increase in the measured quantity for drug vs placebo,
blue a decrease.
L. Barnett et al. NeuroImage 209 (2020) 116462highly multivariate context generally requires large amounts of data to
achieve statistical power; this was unproblematic in the present analysis.
Frequency-domain statistics are defined so that they may be integrated
(averaged) across a given frequency band (Appendix A.3) to yield mea-
sures of FC in specific frequency ranges (Table 3). For GC, the frequency-
domain statistic integrates across the broadband spectrum to yield the
corresponding time-domain statistic.
For both undirected and directed cases, in both time and frequency
domains, we compute three types of measure:4SRC: Per-source unconditional measures, which measure associations
between a single source and all remaining sources.
ROI: Per-ROI pairwise-conditional measures, which measure associa-
tions between pairs of ROIs, conditioned on all other sources, and.
GLO: Intra-ROI global-conditional measures, which measure the total
statistical association of all sources within an ROI, conditioned on all
sources lying outside the ROI.
The GLOmeasures may be interpreted in terms of “density” of within-
ROI statistical associations, in the spirit of (undirected) multi-
Fig. 2. Spectral power for representative single subjects: drug (blue) vs. placebo (red). Lines plot auto-power for the 90 sources.
L. Barnett et al. NeuroImage 209 (2020) 116462information (Studený and Vejnarova, 1998) and (directed) causal density
(Seth, 2009; Seth et al., 2011), or global transfer entropy (Barnett et al.,
2013). Note that pairwise-conditional measures are only calculated on an
ROI-ROI, rather than source-source basis. The reason for this is that the
substantial number (90) of sources implies 89 90 (directed) or 89 45
(undirected) simultaneous statistical test hypotheses. As might be ex-
pected (and as we confirmed), correction for multiple hypotheses (see
Section 2.4 below) results in insufficient statistical power for meaningful
inference.
Details of the functional connectivity measures and their imple-
mentation on the dataset can be found in Appendix A.
2.4. Statistical inference
All time-domain 2nd-order statistics (Appendix A) take the form of
log-likelihood ratios in finite sample, so that the classical large sample
theory (Neyman and Pearson, 1928; Wilks, 1938; Wald, 1943) applies,
yielding asymptotic F or χ2 distributions for their sample estimators.
Sampling distributions for the frequency-domain statistics are generally
not known analytically; we derive them empirically by sub-
sampling/surrogate data methods. We used a False Discovery Rate (FDR)
correction for multiple hypotheses per-drug/subject/condition/
measure4 For the directed FC measures, variation of empirical model4 We use the FDR algorithm of Benjamini and Yekutieli (2001), which does
not assume only positive correlations between test statistics.
5order per-drug/subject may introduce a source of bias; however, given
the large number of sample observations per subject/condition (i.e.,
number of epochs  MEG observations per epoch), bias and variance,
estimated from the corresponding χ2 distribution under the null hy-
pothesis, were an order of magnitude smaller than typical
between-condition changes in the statistical measures, and could thus be
safely ignored. Cross-subject statistical comparisons of FC measures be-
tween conditions (drug vs placebo) were carried out using Wilcoxon’s
signedranktest (Wilcoxon, 1945) (paired t-tests could not be used since
sample estimators are non-Gaussian). The rank correlation, defined as
Wilcoxon’s W-statistic normalised by the total rank sum to lie between 
1 and þ 1, is presented as an effect size in all results. Significance is
presented at α ¼ 0:05, with FDR multiple-hypothesis adjustment.
3. Results
3.1. Spectral power
Before analysing FC, we first examine cross-subject changes in spec-
tral power between drug and placebo. For LSD, psilocybin (PSI), and
ketamine (KET), results (Fig. 1) are broadly consistent with Muthuku-
maraswamy et al. (2013) [PSI] and Carhart-Harris et al. (2016) [LSD],
and reveal a similar effect for sub-anesthetic ketamine. For LSD, PSI, and
KET there is a general decrease in spectral power across all frequency
bands, but especially in the δ–β bands. For tiagabine (TGB), by contrast,
there is a slight increase in spectral power in δ α. Fig. 2 plots spectral
Fig. 3. Time domain, unconditional (SRC): change in undirected (MI) vs. change in directed (GC) FC measures between single source and rest of brain. Top row:
undirected; middle row: directed, inbound; bottom row: directed, outbound.
L. Barnett et al. NeuroImage 209 (2020) 116462power for the 90 sources for a representative single subject for each drug.
For the psychedelics, there is a decrease in spectral power in the δ–β
range against an approximately 1=f background, and, in line with pre-
vious analyses (Muthukumaraswamy et al., 2013), there is also a slight
shift of the α peak to a higher frequency, most obviously for LSD [see
Muthukumaraswamy and Liley (2018)].
3.2. Functional connectivity
We next examine changes in per-source undirected (MI) and directed
(GC) time-domain FC for drug vs placebo. Fig. 3 shows changes in the
unconditional per-source measures (SRC): undirected (top row), directed
inbound (middle row) and directed outbound (bottom row).
For the directed measures, inbound and outbound, there are signifi-
cant decreases in FC across all the psychedelics (as compared with pla-
cebo), while for tiagabine there is an increase. Results for undirected
measures are less clear: for LSD and tiagabine there are significant in-
creases in MI, while for psilocybin and ketamine results are inconclusive.
Notably, within the psychedelics, effect sizes for LSD are generally
stronger than for psilocybin or ketamine.
Figs. 4–6 decompose the per-source time-domain results by fre-
quency. For the undirected case, Fig. 4 shows that the increase in MI in
LSD is strongest in the γ-band (but see Section 4.4). While results for
psilocybin and ketamine are statistically weak, there is a suggestion of a
slight increase in γ. For tiagabine the increase is strongest in δ and θ.
These observations suggest a distinct mechanism of action underlying
increases in MI in tiagabine as compared with the psychedelics. (We
interpret the γ-band results cautiously, given potential for confounds due
to muscle artefact; see Section 4.4.)
Figs. 5 and 6 reinforce the time-domain results for changes in the
directedmeasures. For the psychedelics, the decrease in GC is broadband,
particularly for LSD (for psilocybin the decrease is stronger in α γl). For
tiagabine, the increase in inbound GC is strongest in δ θ, while for
outbound GC it is evenly spread across the spectrum.
We next examined the regional specificity of changes in directed and
undirected FC. Fig. 7 presents results for the inter- and intra-ROI mea-
sures (ROI and GLO). The left-hand column displays changes between6drug and placebo for undirected (MI) measures. The right-hand column
displays results for the directed (GC) measures. For MI, differences for
psilocybin and ketamine are again small (cf. Figs. 3 and 4). For LSD, the
increase in MI is strongest between the occipital region and other ROIs,
particularly the cingulate region. For tiagabine, the increase in MI is
pronounced between the parietal and frontal/limbic/occipital regions,
again suggesting a distinct mechanism. Intra-ROI changes in MI are
weaker than inter-ROI changes. Turning to directed measures, for LSD
decreases in GC are cortex-wide, both within and between ROIs. For
psilocybin, the decrease is strongest between the parietal and other re-
gions, although intra-region increases are only slight. For ketamine, the
strongest decreases are from other ROIs to the parietal and occipital re-
gions, with significant intra-ROI decreases in occipital, parietal and
sensorimotor regions. For tiagabine, the increase in GC is fairly evenly
spread across the cortex, with the exception of the occipital region (there
is also a significant decrease in intra-ROI directed connectivity in the
occipital region).
Summarising, comparing psychedelics with placebo reveals signifi-
cant decreases in GC, widespread across cortical regions and across fre-
quency bands, and which are most pronounced for LSD. These decreases
in directed FC contrast with either little change, or increases, in undi-
rected FC as measured by MI. The non-psychedelic GABA reuptake in-
hibitor tiagabine shows increases in both GC and MI, compared with
placebo.
To verify that these results reflect meaningful changes in directed and
undirected FC, we conducted further analyses to explore whether the
observed changes in MI and GC could be accounted for by (i) changes in
power spectra, including effects of signal-to-noise ratio (SNR), and (ii)
changes in residuals correlation in the VAR modelling of the data.
3.3. Relation between changes in undirected and directed FC
A novel feature of our analysis is that we compare GC and MI on the
same data, and we see in our empirical results a variety of ways in which
they relate to each other. Thus (Fig. 3) we see the striking opposite
movement for LSD, same-direction movement for TGB, while for the
other psychedelics (PSI and KET) the decrease in GC is not obviously
Fig. 4. Frequency domain, unconditional (SRC): change in undirected FC (MI) between single source and rest of brain.
L. Barnett et al. NeuroImage 209 (2020) 116462accompanied by increases in MI. To better understand the extent to
which GC and MI are reflecting distinct aspects of neural dynamics, we
conducted further theoretical, modelling, and empirical analyses.
3.3.1. Spectral power and signal-to-noise ratio
Existing functional analyses of the psychedelic state (Riba et al., 2004;
Muthukumaraswamy et al., 2013; Carhart-Harris et al., 2016; Pallavicini
et al., 2019) have concentrated on changes in spectral power (Section
3.1). We therefore wondered whether the decreased directed functional
connectivity we observed might have a straightforward explanation in
terms of changes in spectral power. This possibility can be reasonably
rejected for the following reason: previously conducted power analyses7have focused on auto-spectral power, and have revealed generally
broadband decreases in the psychedelic state - as we also find (Figs. 1, 2).
Such broadband changes most likely reflect a rescaling of neural signals
(but see below). Critically, Granger causality is scale invariant (Barrett
and Barnett, 2013). In fact, more generally, Granger causality is invariant
under (invertible) filtering (Geweke, 1982; Barnett and Seth, 2011).
Therefore, changes to auto-spectra are not by themselves informative
about how GC might be expected to change. Because GC depends on the
full cross-power spectrum—in complicated ways (Dhamala et al.,
2008)—our results cannot be readily accounted for in terms the observed
changes in broadband auto-spectra.
Another possibility is that the decrease in directed FC between pla-
Fig. 5. Frequency domain, unconditional (SRC): change in directed (inbound GC) FC between single source and rest of brain.
5 Preliminary mathematical analysis, which we intend to publish as a separate
study, indicates that in general a decrease in SNR is associated with a decrease
L. Barnett et al. NeuroImage 209 (2020) 116462cebo and drug conditions might be due to changes in signal-to-noise ratio
(SNR). Previous studies (Muthukumaraswamy et al., 2013; Carhar-
t-Harris et al., 2016) indicate that the psychedelic drugs are associated
with a decrease in SNR; this is corroborated by our results for spectral
power changes in the psychedelic conditions (Figs. 1, 2). To test whether
a reduction in SNR might account for a reduction in directed FC, we
investigated whether the addition of correlated, additive broadband
white noise [representing a mixture of highly correlated room noise plus
uncorrelated sensor noise (Vrba and Robinson, 2001)] to the placebo
data could reproduce the time-domain FC results. Results, illustrated in
Fig. 8, demonstrate that a sufficient level of additive noise ( 20 dB) to
roughly emulate the decrease in GC seen in Fig. 3, also results in a strong8decrease in MI,5 in direct contrast to Fig. 3. We thus conclude that a
decrease in SNR in the psychedelic state is highly unlikely to account for
the observed changes in FC.
3.3.2. Empirical and theoretical relationship between GC and MI
The opposite movement of GC and MI seen in LSD—as well as the
same-direction movement in tiagabine—are striking and deserve further
analysis. One might think, a priori, that directed and undirected measuresin both GC and MI.
Fig. 6. Frequency domain, unconditional (SRC): change in directed (outbound GC) FC between single source and rest of brain.
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information flow (as measured by GC). However, formally, mutual in-
formation and information flow are not directly related. That is, there is
no theoretical reason to expect that a decrease (due to LSD, for example)
in GC between two ROIs should be associated with an increase in MI, or
vice-versa.
To probe the relationship between GC and MI in our data, we per-
formed the following empirical analysis: firstly, for each drug and (pla-
cebo/drug) condition, we calculated cross-subject correlation (Kendall’s
τ) between GC and MI, both inter- and intra-ROI. Results (not shown)
indicated weak evidence (non-significant at 95% level after an FDR
correction) for some anti-correlation, and, for ketamine only, a marginal9increase in anti-correlation moving from placebo to drug condition. Next,
for each drug we investigated cross-subject correlation between ΔGC ¼
GCðdrugÞ  GCðplaceboÞ andΔMI ¼MIðdrugÞMIðplaceboÞ; that is, we
asked empirically whether larger changes in undirected measures cor-
responded with larger changes in directed measures. As Fig. 9 shows,
there is again scant evidence for any consistent effect; for specific ROIs,
change in the measures were sometimes found to be correlated and
sometimes anti-correlated; but again statistical significance was lacking.
To further investigate this issue we conducted a theoretical analysis,
examining the relationship between MI and GC for the stationary
bivariate, VAR(1) model
Fig. 7. Time domain, inter-ROI pairwise-conditional (ROI) and intra-ROI
global-conditional (GLO): change in undirected vs. change in directed mea-
sures between ROIs (Table 1), conditioned on rest of brain. The top row of each
panel (GLO) shows effect sizes per column for the global-conditional intra-ROI
measures (GLO). The undirected plots are symmetrical; for the directed plots,
row label references “to” ROI, column label “from” ROI. White dots indicate a
statistically significant cross-subject effect at α ¼ 0:05, Wilcoxon signed-rank
test, with FDR correction (see Section 2.4).
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10Xt ¼ aXt1 þ cYt1 þ εxt
Yt ¼ bYt1 þ εyt (1)with unidirectional GC and residuals correlation ρðεxt ; εytÞ ¼ κ; see Ap-
pendix B for details.
Fig. 10a and Fig. 10b display heat maps of MI IðX : YÞ and GC
FðY→ XÞ for κ ¼ 0, fixed a, and b; c varying within the model parameter
space. The green arrows indicate the direction of steepest gradient
rIðX : YÞ, while the magenta arrows indicate the direction of steepest
gradient rFðY→ XÞ for GC. At a given point in parameter space, the
angle θ between the gradients is given by (Appendix B)
cosθ¼ rIðX : YÞ ⋅rFðY → XÞk rIðX : YÞ k k rFðY → XÞ k (2)
The cosine isþ1 when the gradients are in exactly the same direction,
1 when they point in opposite directions and 0 when they are orthog-
onal (Fig. 10c). For κ ¼ 0, the gradients never point in opposite di-
rections, but (Fig. 10d–f) this is not necessarily the case for κ 6¼ 0.
Together, these figures show that there will always be directions in
parameter space where MI and GC will be changing either in the same, or
in opposite, directions. Analysis of this minimal VAR model therefore
further establishes that GC and MI can move independently under vari-
ations in the underlying data generating process.
Given that GC and MI (i) need not change together, as established
theoretically and via modelling, and (ii) generally do not move togeth-
er—at least not consistently—as shown by the heterogeneity in the
relation between GC and MI across the different drugs (Fig. 9), what
could explain the striking opposite movement in the specific case of LSD?
One possibility relates to correlations between the residuals in the
corresponding VAR models.6 In our minimal VAR model, the behaviour
of the MI and GC gradients as residuals correlation κ changes is striking.
In Appendix B we derive explicit expressions for ∂∂κ FðY→ XÞ and
∂
∂κ IðX : YÞ. Extensive simulations show that, for any values (except c ¼ 0)
in the (a;b;c;κ) parameter space, the signs of these quantities are always
opposite. Thus any change in residuals correlation always results in an
opposite movement of MI and GC. For at least half of the entire parameter
space (in the minimal VARmodel), increasing κ (i.e., increasing residuals
correlation) always leads to increasing MI coupled with decreasing GC,
while for the other half, increasing κ leads to decreasing MI coupled with
increasing GC (Fig. 10, right column). Therefore, even though a change
in residuals correlation is consistent with the empirical changes in MI and
GC observed with LSD, it is less consistent with PSI (where an increase in
residuals correlation accompanies a decrease in GC but no significant
change in MI), and not at all with KET (where there is no change in re-
siduals correlation), or with TGB (where a decrease in residuals corre-
lation leads to increases in both GC and MI). These analyses therefore
indicate that changes in residuals correlations cannot readily explain the
pattern of empirical results across all drugs.
Fig. 11 displays drug vs. placebo change in residuals correlation for
the VAR models (i.e., the models fitted to the MEG data, not the minimal
VAR model discussed above). For LSD and psilocybin, there is a statis-
tically significant increase in residuals correlation in the drug condition,
while for tiagabine there is a statistically significant decrease. On the
assumption that the minimal VAR model result—that any change in re-
siduals correlation between conditions leads to the opposite movement of
directed and undirected FC—generalises to more complex network sce-
narios, it is unlikely that changes in residual correlation can explain the
relationship between directed and undirected FC that we observe across
all drugs. (In addition, while for KET there are hints of an increase in6 Preliminary investigations suggest that increased residuals correlation may
potentially (but not conclusively) indicate the presence of latent (unmeasured)
common influences on the system dynamics; intuitively, linear modelling “sees”
the effect of common—but unmodelled—inputs as correlated noise.
Fig. 8. Time domain, unconditional (SRC): change in undirected vs. change in directed FC measures between single source and rest of brain (psychedelic drugs) for
placebo vs. placebo þ additive, correlated noise. Top row: undirected; middle row: directed, inbound; bottom row: directed, outbound. Additive noise was at a level of
 20 dB, with a Pearson correlation coefficient of ρ  0:9 between sources.
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changes in residuals correlation). Therefore, alterations in residuals
correlation might account for the pattern of results for LSD but cannot
account for the pattern in general. We have not established the extent to
which our minimal VAR result generalises; but even in that model there
are other possible structural mechanisms which may drive the effect
which do not involve residuals correlation (cf. Fig. 10, left column).
Altogether, the mechanistic processes underlying the relative changes
in directed and undirected FC in the different drug conditions remain to
be fully elucidated. Importantly, though, the changes we observe cannot
readily be explained away in terms of changes in power auto-spectra,
signal-to-noise ratio, or residuals correlation.
4. Discussion
In this exploratory study, we examined the effects of three psyche-
delic drugs on large-scale brain dynamics in terms of directed functional
connectivity (FC). Unlike more familiar undirected FC measures, such as
correlation and coherence, directed FC measures take into account
temporal dependencies in the data, potentially delivering fresh insights
into alterations to neural dynamics, and more specifically into changes in
information flow both between and within brain regions.
We applied both directed FC measures (Granger causality/informa-
tion flow) and undirected measures (correlation/mutual information), in
time and frequency domains, to source-localised MEG data obtained in
resting state conditions, contrasting placebo against three different psy-
chedelics (LSD, psilocybin, low-dose ketamine), as well as against a non-
psychedelic control, tiagabine. Our main result revealed a consistent
broadband decrease in information flow in psychedelic conditions, both
between and within brain regions, broadly across cortex. In the case of11LSD, this decrease in information flow was accompanied by an increase
in undirected FC. By contrast, for the tiagabine control, we observed
increases in both directed and undirected FC in the drug condition.
Further empirical and theoretical analyses examined whether these
changes in FC could be accounted for by changes in power spectra, signal-
to-noise ratio, or correlation between the residuals of the predictive VAR
models used to derive FC statistics. We verified that the observed changes
in directed and undirected FC could not readily be accounted for by these
factors.
4.1. Power spectra
We first identified a substantial reduction in broadband spectral
power in the psychedelic state. This is a relatively well established effect,
which has been described in several previous studies: see, e.g., Fink
(1969) (LSD, mescaline/EEG), Riba et al. (2004) (ayahuasca/EEG),
Muthukumaraswamy et al. (2013) (psilocybin/MEG) and Carhart-Harris
et al. (2016) (LSD/MEG). Recently, Pallavicini et al. (2019) analysed
spectral changes in LSD, psilocybin and ketamine using the same MEG
dataset as used in this study. They report region-specific patterns of
spectral power reduction in the alpha and theta bands common to LSD
and psilocybin, as well as changes in the beta band common to all three
drugs. Our spectral analyses (Fig. 1) are consistent with these findings, as
would be expected given we analyse the same data. Interestingly,
accompanying these broadband reductions in power, we also note a
(small but significant) upward shift in the alpha peak frequency (Fig. 2),
which is most evident for LSD (Walter, 1957; Carhart-Harris et al., 2016;
Muthukumaraswamy and Liley, 2018). The mechanisms and relevance of
this peak shift remain unclear.
Fig. 9. Inter- and intra-ROI correlation between ΔGC ¼ GCðdrugÞ  GCðplaceboÞ and ΔMI ¼ MIðdrugÞ MIðplaceboÞ. Correlation is calculated, per ROI pair (intra,
ROI) or ROI (intra, GLO) as Kendall’s τ rank-correlation statistic, in range ½  1;1. There was no statistically significant correlation at 95% confidence (after a per-plot
FDR multiple-hypotheses correction).
L. Barnett et al. NeuroImage 209 (2020) 1164624.2. Functional connectivity and signal variability
By charting patterns of connectivity across brain regions, FC analyses
offer a detailed picture of how neural dynamics are altered in psychedelic
states. Our primary finding of decreased directed information flow
speaks to a disintegration of communication between and within brain
regions, which in turn implies a loosening of dynamical constraints on
brain activity in the psychedelic state. This loosening may correspond to
an increased repertoire of dynamical states, in line with theoretical
proposals that link increased dynamical diversity to the characteristic
subjective effects of psychedelics including unconstrained cognition,
perception, and ego-dissolution (Carhart-Harris et al., 2014; Atasoy et al.,
2018; Carhart-Harris, 2018; Carhart-Harris and Friston, 2019).
Our results are most directly comparable to other studies of the psy-
chedelic state using EEG or MEG. In particular, in a previous analysis of
the same dataset (except the tiagabine control), we see increased Lempel-
Ziv complexity, which can be considered as a measure of signal diversity
across time and/or space (Schartner et al., 2017), for all psychedelics
(compared with placebo). This increase in diversity is in line with an
increased repertoire of brain dynamics during the psychedelic state.
However, unlike the present study, this previous study did not analyse
connectivity of any kind. Other EEG and MEG studies (Kometer et al.,122015; Alonso et al., 2015; Rivolta et al., 2015; Pallavicini et al., 2019)
have applied FC measures, but did not systematically compare directed
and undirected measures, and did not compare results across a range of
psychedelics (see Introduction).
fMRI studies of altered FC and signal variability in the psychedelic
state are more common than M/EEG studies. These fMRI studies have
revealed a wide range of effects across a range of different psychedelics.
Some reported effects support an increased dynamical repertoire in the
psychedelic state. Among these studies are those which employ measures
of signal variability. In a relatively early study, Tagliazucchi et al. (2014)
report a wider repertoire of connectivity states following psilocybin
administration. Lebedev et al. (2016) calculate voxel-level sample en-
tropy from resting-state fMRI data, comparing LSDwith placebo, and find
increased entropy in sensory and higher networks across multiple time
scales. Viol et al. (2017) estimate functional brain networks from
resting-state fMRI data recorded under ayahuasca, finding an increase in
the entropy of the network degree distribution (a measure of network
complexity) in the drug state. Atasoy et al. (2017) perform a “con-
nectome-harmonic decomposition” of brain activity based on fMRI re-
cordings under placebo and LSD (connectome harmonics are identified as
spatial patterns reflecting synchronisation of activity at different spatial
scales). They too report an expanded repertoire of active brain states
Fig. 10. Left column: heat maps of IðX : YÞ(a) and FðY→ XÞ (b) for the VAR model (1) with κ ¼ 0, for fixed a and b; c varying over parameter space. Green arrows
indicate the direction of steepest gradient rIðX : YÞ, while the magenta arrows indicate the direction of steepest gradient rFðY→ XÞ. Fig. (c) displays a surface plot of
cosθ, where θ is the angle between the gradients of IðX : YÞ and FðY→ XÞ with κ ¼ 0, for fixed a and b; c varying over parameter space. cosθ is þ 1 when the gradients
point in the same direction, 1 when they point in opposite directions, and 0 when they are orthogonal. Right column: heat maps of the gradient of FðY→ XÞ (d) and
IðX : YÞ (e) with respect to κ plotted against causal strength c and residuals correlation κ, for a ¼ 0:3; b ¼ 0:4. In Fig. (f), the region where IðX : YÞ increases and
FðY→ XÞ decreases with increasing κ is marked in grey.
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of neural dynamics during the psychedelic state, which is consistent with
our finding of decreased FC in these states.
Other fMRI studies have focused on measures of undirected FC. These
studies have revealed a range of altered patterns in the psychedelic state,13including decreased coupling between "connectivity hub" brain regions
(Carhart-Harris et al., 2012); changes in connectivity within and across
resting state networks that correlate with subjective effects (Carhar-
t-Harris et al., 2016), and global increases in (undirected) FC in
high-level association cortices and the thalamus, correlating with
Fig. 11. VAR residuals correlations, measured as multi-information of the re-
siduals normalised by the multi-information of a uniform random correlation
matrix of the same size. The figure plots median residual correlations across
subjects, with error bars at 1 mean absolute deviations.
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number of fMRI studies have examined modifications of connectivity at
sub-anesthetic doses of ketamine. However, a confusing pattern emerges
in these papers, with some showing increases in connectivity (Driesen
et al., 2013; Anticevic et al., 2015; Dandash et al., 2015), whereas others
show decreases (Kraguljac et al., 2017; Wong et al., 2016). This pattern
may be related to the many different analytical techniques to both pre-
process and quantify FC in the BOLD data. These observations of in-
creases and decreases in FC are difficult to directly compare with the
present results, given the slow temporal dynamics of the fMRI BOLD
signal, but they are by-and-large consistent with the idea of an increased
repertoire of brain dynamics during the psychedelic state. We note that
directed measures of FC, such as Granger causality, remain controversial
when applied to fMRI because of the slow nature of the BOLD signal (Seth
et al., 2013; Solo, 2016; Barnett and Seth, 2017).4.3. Directed and undirected functional connectivity
A unique feature of the present analysis is the comparison of directed
(Granger causality) and undirected (correlation and coherence) on the
same data. This comparison is permitted by the high-temporal resolution,
accurate source-localisation, and steady-state nature of the MEG re-
cordings, which are ideally suited for the application of rigorous and
robust directed FC analyses.
As already mentioned, our primary finding of decreased directed FC
across all psychedelics (but not tiagabine) is in line with the notion of an
increased repertoire of brain dynamics in the psychedelic state. There is a
broader relevance to this finding, highlighted by the independent
movement of directed FC and undirected FC (correlation and coherence)
in our analyses. Had we examined only the more familiar measures of
undirected FC, we would have drawn very different conclusions about
the influence of psychedelics on global brain dynamics. In principle,
directed FC measures (such as Granger causality) and undirected mea-
sures (such as correlation and coherence) offer distinct and independent
perspectives on neural dynamics. Our study shows that this “in principle”
difference also matters in practice. Future EEG/MEG studies of functional
connectivity, both in the context of psychedelics and beyond, should
therefore consider applying both directed and undirected FC measures in
order to gain a comprehensive picture of neural dynamics, especially for
exploratory analyses.14It bears emphasising that FC analyses, whether directed or undi-
rected, are distinct from EC analyses (EC; Friston et al., 2013; Seth et al.,
2015). At the most general level, FC describes statistical dependencies
between variables, whereas EC aims to identify the minimal causal circuit
underlying some observed activity pattern (Barrett and Barnett, 2013).
Intuitively, FC provides a description of dynamics, while EC [as oper-
ationalised by techniques such as dynamic causal modelling; see Friston
et al. (2003)] provides an inference about underlying mechanism.
Although the FC statistics we employ, such as Granger causality, are
frequently operationalised via parametric modelling, these stochastic
process models do not stand as mechanistic descriptions of neural dy-
namics, but as generic time-series models (Barnett et al., 2017). In FC
approaches (both directed and undirected) the metrics derived have
information-theoretic interpretations (Barnett et al., 2009; Barnett and
Bossomaier, 2013), and since the generic models are comparatively
low-dimensional, these approaches are well suited to exploratory anal-
ysis of the type performed in this study.
4.4. Limitations
Our analysis has several limitations. First, it is difficult to completely
exclude that artefacts due to fine muscle movements may have affected
the MEG signal differently in drug as compared with placebo conditions.
This concern applies in particular to LSD, where it applies primarily to
higher frequency bands - notably the γ-band. While caution should be
therefore be applied to results in these high frequency bands, we note
that our main findings apply across all frequency bands, providing
reassurance that muscle artefacts cannot readily explain our data.
A second limitation, which again applies primarily to LSD, is that the
MEG recordings represent only a brief snapshot of an 8-hour psychedelic
experience. Further research is needed to examine any possible time-
varying dynamics of information flow across an entire “trip”.
Thirdly, we note that tiagabine recordings (drug and placebo) were
carried out with eyes closed, whereas the other recordings were carried
out with eyes open. However, comparisons between drug and placebo
did not mix eyes-open and eyes-closed conditions, reassuring that this
difference is unlikely to have affected our conclusions. Finally, inherent
limitations on statistical power due to comparatively small (subject)
sample sizes may have prevented us characterising more fine-grained
alterations in information flow engendered by psychedelics.
5. Summary
We measured directed and undirected functional connectivity in
source-localised MEG data recorded while healthy human volunteers
experienced a psychedelic state (LSD, psilocybin, or low-dose ketamine),
placebo, or a control state (tiagabine). We found that the psychedelic
state is associated with a general decrease in directed functional con-
nectivity (information flow), sometimes (in particular for LSD) accom-
panied by an increase in undirected functional connectivity (correlation).
These changes in directed functional connectivity were not explainable
by accompanying changes in spectral power, signal-to-noise ratio, or
other features of the underlying statistical models (residuals correlation).
The generalised decrease in information flow we observed is consistent
with notions of an increased dynamical flexibility or repertoire in the
psychedelic state (Carhart-Harris et al., 2016; Carhart-Harris, 2018;
Carhart-Harris and Friston, 2019).
The distinct and in some cases (LSD) opposite movement of directed
and undirected measures suggests that analyses of functional connec-
tivity should, especially when exploratory, analyse both kinds of measure
in order to deliver a comprehensive picture of underlying neural dy-
namics. Future research would usefully probe how directed and undi-
rected FC measures behave with respect to each other in other contexts,
besides psychedelics. The methods described here provide a viable,
statistically-sound pipeline for implementing such analyses given
epoched, multivariate neurophysiological data with reasonable temporal
L. Barnett et al. NeuroImage 209 (2020) 116462and spatial resolution.
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For each drug, subject and condition we take each 2s MEG epoch as a realisation of a stationary multivariate stochastic process Xt ¼ fXitg where t
indexes time steps and i indexes localised sources corresponding to the 90 AAL regions. The information-theoretic and frequency-domain measures
described below are estimated under Gaussian assumptions as 2nd-order statistics, based on vector-autoregressive (VAR) modelling (Hamilton, 1994;
Lütkepohl, 1993).7 Here, the (zero-mean) process Xt is modelled as a (finite-order, stable and invertible) vector autoregression
Xt ¼
Xp
s¼1
AsXts þ εt (A.1)
with white noise (iid, serially-uncorrelated) residuals εt . The model parameters are the regression coefficients matrices A1;…;Ap, and the variance-
covariance matrix Σ ¼ E½εtεTt . For each drug, subject and condition, a model order p must first be selected; here we used a likelihood-ratio F-test
(Hamilton, 1994); p generally varied between 2 and 5 (Table 4). Model parameters were then identified from the normalised time-series data using an
LWR maximum-likelihood estimator due to Morf et al. (1978).
Appendix A.1 Undirected measures: partial correlation and partial coherence
Given jointly-distributed multivariate random variables X;Y ;Z, we have the conditional mutual information IðX : Y jZÞ. Mutual information (Cover
and Thomas, 1991) quantifies the degree to which two jointly-distributed variables are statistically dependent. In the case that X and Y are univariate
and X;Y ; Z are jointly multivariate-normally distributed, IðX : Y jZÞ ¼ log½1 ρðX;Y jZÞ2, where ρðX;Y jZÞ is the conventional partial correlation co-
efficient, so that IðX : Y jZÞ is a monotonic function of the (squared) partial correlation8; in this sense IðX : YjZÞ generalises partial correlation to
multivariate (and non-Gaussian) variables. Under Gaussian assumptions:
I

X : Y
Z

¼ log jVðXjZÞj jVðY jZÞjjVðX;Y jZÞj (A.2)
where VðXjZÞ;VðX;Y jZÞ, etc., denote partial variance-covariance matrices, j⋯j denotes a determinant, and “log” always denotes natural logarithm.
If X ¼ fXig is multivariate, a conditional version of multi-information can be defined as IðXjZÞ. Multi-information (Studený and Vejnarova, 1998)
quantifies the degree to which a jointly-distributed set of variables are mutually dependent. Under Gaussian assumptions, multi-informationmber of subjects per drug (Table 2). Left-hand columns:
Ketamine (19) Tiagabine (15)
4 3 4 5
3 2 4 4
4 3 4 4
3 3 4 5
4 3 5 4
3 3 4 4
4 3 4 4
4 3 4 4
3 2 4 5
4 3 5 4
3 3 4 4
4 3 4 4
3 3 4 4
4 3 5 4
4 3 4 4
3 3
3 3
3 3
3 2
(partial correlation/coherence) from standard maximum-likelihood variance-
estimated in sample by a multi-taper method with aggregation over epochs
case, this would not make sense in any case.
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IðXjZÞ¼ log
Q
iVðXijZÞ
jVðXjZÞj (A.3)
which is the basis for the (undirected) global-conditional measure we use (GLO).
In the frequency domain, we use 2nd-order statistics as for the time-domain Gaussian case above, but based on the cross-power spectral density
(CPSD) matrices SðX;ωÞ, etc., rather than the covariancematrices VðXÞ, where ω denotes frequency (in Hz) on the rangeω 2 ½0; ν =2with ν the sampling
frequency. We thus consider the measure
c

X : Y
Z;ω¼ log jSðXjZ;ωÞj jSðY jZ;ωÞjjSðX;Y jZ;ωÞj (A.4)
In case X;Y are univariate, cðX : Y jZ;ωÞ is the logarithm of the standard partial coherence measure. For multivariate processes, we also have the global-
conditional spectral measure [cf. (A.3)]
cðXjZ;ωÞ¼ log
Q
iSðXijZ;ωÞ
jSðXjZ;ωÞj (A.5)
Appendix A.2 Directed measures: Granger causality in time and frequency domain
Directed connectivity measured are based on Granger causality (GC) (Wiener, 1956; Granger, 1963, 1969; Geweke, 1982), a 2nd-order statistic for
stochastic time-series based on optimal linear prediction. We use Geweke’s multivariate conditional form (Geweke, 1984) in time and frequency do-
mains. Although the mathematics of GC have been well described previously [see, e.g., Barnett and Seth (2014)], we specify our derivation below in
order to prevent ambiguity in interpretation, especially for the more complex cases of conditional GC in the frequency domain.
Let Xt (target), Yt (source) and Zt (conditioning variable) be jointly-distributed, wide-sense stationary (possibly multivariate) processes. The optimal
linear predictor (in the least-squares or maximum-likelihood sense) of X based on the past histories of X;Y ;Z is given by the conditional expectation
EðXt
Xt ;Yt ;Zt Þ, where Xt ¼ ½Xt1;Xt2;…, etc., denotes the history of a process up to the previous time step. The residual prediction errors are then
εt ¼ Xt  EðXt
Xt ;Yt ;Zt Þ; we denote the covariance matrix of residual errors—a measure of predictive efficacy—by Σ ¼ E½εtεTt . Now consider the
optimal predictor EðXt
Xt ; Zt Þ of X based on the histories of X and Z alone; i.e., omitting the source variable Y. The residuals of this “reduced” predictor
can be written as εRt , and its covariance matrix as Σ
R ¼ E½εRt εRTt . Then the (time-domain) GC from source Y to target X conditional on Z is defined to be
FðY→XjZÞ¼ log jΣ
Rj
j Σ j (A.6)
and may be interpreted intuitively as “the degree to which Y predicts the future of X, over and above the degree to which X already predicts its own
future, controlling for Z”. In finite sample, the infinite histories Xt , etc., are replaced by ½Xt1;…;Xtp, etc, where p is the selected model order [cf.
(A.1)], and the statistic (A.6) becomes a log-likelihood ratio.
Since GC, as a directed measure, is not symmetrical in the source and target variables, we have an inbound and an outbound version of the un-
conditional form (SRC), corresponding respectively to system→source and source→system information flow. For multivariate processes Xt ¼ fXtig,
analogous to conditional multi-information in the undirected case, a global-conditional measure (GLO) may be defined as the sum of conditional
causalities from X itself to each individual variable Xi (Barnett et al., 2013):
FðXjZÞ : ¼
X
i
FðX½i→XijZÞ (A.7)
where subscript ½i denotes omission of the ith index.
Geweke also introduced a spectral (frequency domain, conditional) GC statistic, written here as f ðY→ XjZ;ωÞ; for details see Geweke (1982, 1984).
A corresponding global-conditional measure f ðXjZ;ωÞ can be defined asPif ðX½i→ XijZ;ωÞ.
For empirical data, we calculate GC in time and frequency domain from the estimated VAR parameters using a state-space method (Hannan and
Deistler, 2012; Barnett and Seth, 2015; Solo, 2016).9
Appendix A.3 Frequency-band averaging
The relationship between time- and frequency-domain measures is underpinned by Szeg€o’s Theorem, which yields (Rozanov, 1967):
1
ν
Z ν
0
logjSðωÞj dω¼ logjΣj (A.8)9 A subtlety is that reduced VAR model parameters must be calculated directly from the full model; separate full and reduced regressions are known to induce strong
biases, particularly in the frequency domain (Chen et al., 2006; Barnett and Seth, 2014; Barnett et al., 2017). Here we used a hybrid technique involving just the full
regression (A.1), with reduced model parameters calculated using the state-space method of Barnett and Seth (2015).
16
L. Barnett et al. NeuroImage 209 (2020) 116462where ν is the sampling frequency. As a corollary, spectral GC integrates across the broadband spectrum to yield the corresponding time-domain
measure (Geweke, 1984):
1
ν
Z ν
0
f ðY→XjZ;ωÞdω¼FðY→XjZÞ (A.9)
This relation thus holds for the directed spectral measures10. In general, all the frequency-domain measures (undirected and directed) can be integrated
(averaged) over a frequency band ½ω1;ω2 to yield a “band-limited” measure (Barnett and Seth, 2011) 1ω2ω1
R ω2
ω1
ϕðωÞ dω, where ϕðωÞ represents any of
our spectral measures. All frequency-domain results in Section 3 are presented as band-limited over the frequency bands in Table 3.
Appendix B. Correlation and Granger causality (GC) for a minimal VAR model
We start by examining the simplest bivariate system:
Xt ¼ aXt1 þ cYt1 þ εxt (B.1)
Yt ¼ bYt1 þ εyt (B.2)
or
Ut ¼AUt1 þ εt (B.3)
where Ut 

Xt
Yt

is the bivariate vector process, A ¼

a c
0 b

the VAR coefficients matrix and Σ  E½εtεTt  ¼

1 κ
κ 1

the residuals covariance matrix.
The AR operator and MA operator (transfer function) are, respectively
ΦðzÞ¼ I Az¼

1 az cz
0 1 bz

(B.4)
ΨðzÞ ¼ ΦðzÞ1 ¼ 1ð1 azÞð1 bzÞ

1 bz cz
0 1 az

(B.5)
In the time domain, zmay be interpreted as the backshift (lag) operator, while in the frequency domain z ¼ eiω lies on the unit circle in complex plane,
where ω is the phase angle, measured in radians. The CPSD may be calculated from the spectral factorisation (Wilson, 1972) SðzÞ ¼ ΨðzÞΣΨðzÞ as
SðzÞ¼ 11 azj21 bzj2
 1 ðb κcÞzj2 þ 1 κ2c2 ½κ þ ðc κbÞzð1 azÞ ½κ þ ðc κbÞzð1 azÞ1 azj2 on
z
¼ 1 (B.6)
(z denotes complex conjugate) so that, in particular, the power spectral density of the sub-process Xt is
SxxðzÞ¼
1 ðb κcÞzj2 þ ð1 κ2Þc21 azj21 bzj2 on
z
¼ 1 (B.7)
We factor this as
SxxðzÞ¼ψðzÞvψðzÞ ¼ v
ψðzÞj2 on z¼ 1 (B.8)
where ψðzÞ  ΨRxxðzÞ; v ¼ ΣRxx are, respectively, the MA operator and residuals variance for the reduced linear representation of the sub-process Xt . By
inspection, we try a reduced spectral factorisation with
ψðzÞ  1 hzð1 azÞð1 bzÞ (B.9)
which yields
v
1 hzj2 ¼ 1ðb κcÞzj2 þ 1 κ2c2 on z¼ 1; (B.10)
or10 For partial coherence/correlation, the analogue of (A.9) does not hold in general, except in the unconditional case.
17
L. Barnett et al. NeuroImage 209 (2020) 116462v

1þ h2¼ 2Δ; Δ  1
2

1þ b2 þ c2  2κbc (B.11)vh¼ b κc (B.12)
This yields the quadratic equation
v2  2Δvþðb κcÞ2 ¼ 0 (B.13)
for v, so that
v¼Δþ
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Δ2  ðb κcÞ2
q
(B.14)
Note that we need the ‘þ ’ sign on the square root, since this yields correctly v ¼ 1 when c ¼ 0.
In the time domain, the mutual information between Xt and Yt is given by
IðX : YÞ ¼ log½1 ρðX;YÞ2
¼ log pþ log q logpq r2 (B.15)
where ρðX;YÞ is the correlation between Xt and Yt , and Ω  E½UtUTt  ¼

p r
r q

is the covariance matrix. To calculate Ω, we need to solve the discrete-
time Lyapunov equation (derived from the Yule-Walker equations)
Ω¼AΩAT þ Σ (B.16)
We find
P¼ a2pþ 2acr þ c2qþ 1 (B.17)
r¼ abr þ bcqþ κ (B.18)
q¼ b2qþ 1 (B.19)
so
q¼ 1
1 b2 (B.20)
r¼ bcqþ κ
1 ab ¼
R
1 b2ð1 abÞ (B.21)
p¼ c
2ð1þ abÞqþ 2κacþ 1 ab
ð1 a2Þð1 abÞ ¼
P
ð1 a2Þ1 b2ð1 abÞ (B.22)
where
R¼ bcþ κ1 b2 (B.23)
P¼ c2ð1þ abÞ þ 1 b2ð1 abþ 2κacÞ (B.24)
We then have
pq r2 ¼ ð1 abÞP ð1 a
2ÞR2
ð1 a2Þ1 b22ð1 abÞ2 ¼
Q
ð1 a2Þ1 b2ð1 abÞ2 (B.25)
where
Q¼ c2 þð1 abÞ2þ 2κcða bÞ  κ21 a21 b2 (B.26)
The MI is thus18
L. Barnett et al. NeuroImage 209 (2020) 116462IðX : YÞ¼ log P log Qþ logð1 abÞ  log 1 b2 (B.27) 
For the Granger causality from Y → X, since Σxx ¼ 1, we have simply
FðY→XÞ¼ log v (B.28)
(the GC from X → Y is trivially zero). We note that the Geweke “total linear dependence” measure (Geweke, 1982, 1984) is given by
LðX : YÞ¼ logΣRxx þ logΣRyy  logjΣj ¼ logv log

1 κ2 (B.29)
(note that ΣRyy ¼ 1). This also follows directly from Geweke’s decomposition of total linear independence into directional and instantaneous terms. We
see immediately that if κ ¼ 0 (zero residuals correlation), then FðY→ XÞ ¼ LðX : YÞ.
In the frequency domain, we have, from the definitions,
c
 
X : Y ;ω
!
 log
"
SxxðzÞSyyðzÞ
SxxðzÞSyyðzÞ 
SxyðzÞj2
#
(B.30)
f ðY→X;ωÞ  log
"
SxxðzÞ
SxxðzÞ  Σyyjx
ΨxyðzÞj2
#
(B.31)
and straightforward calculation leads to
c

X : Y ;ω
¼ log1 βzj2 þ c21 κ2
 log1 bzj2  log1 κ2 (B.32)
f

Y→X;ω
¼ log1 βzj2 þ c21 κ2
 log1 βzj2 (B.33)
where β  b κc. We see immediately that if κ ¼ 0 then f ðY→ X;ωÞ ¼ cðX : Y ;ωÞ at any frequency ω. Note that f ðY→ X;ωÞ integrates to FðY→ XÞ,
while cðX : Y;ωÞ integrates to LðX : YÞ.
We are, in particular, interested in regions and directions in parameter ða; b; c; κÞ-space along which IðX : YÞ and FðY→ XÞ move in opposite di-
rections. To this end we may calculate the angle θ between the gradient vectors rIðX : YÞ and rFðY→ XÞ:
cosθ¼ rIðX : YÞ ⋅ rFðY → XÞk rIðX : YÞ k k rFðY → XÞ k (B.34)
at a point ða;b;c;κÞ, where “⋅” denotes vector dot-product. The cosine is then þ1 when the gradients are in exactly the same direction,  1 when they
point in opposite directions and 0 when they are orthogonal. Gradients in the κ direction are of particular interest. Noting that ∂Δ∂κ ¼  bc, we may
calculate:
∂v
∂κ¼ 
cðbv bþ κcÞ
v Δ (B.35)
∂P
∂κ ¼ 2ac

1 b2 (B.36)
∂Q
∂κ ¼ 2

cða bÞ κ1 a21 b2
 (B.37)
so that
∂
∂κ FðY→XÞ¼
1
v
∂v
∂κ (B.38)
∂
∂κ IðX : YÞ¼
1
P
∂P
∂κ 
1
Q
∂Q
∂κ (B.39)
Numerically, we may establish that (except at c ¼ 0) ∂∂κ FðY→ XÞ and ∂∂κ IðX : YÞ always have opposite sign; so, keeping the parameters ða; b; cÞ fixed,
either increasing or decreasing κ always moves IðX : YÞ and FðY→ XÞ in opposite directions. We stress, however, that we have not established that this
necessarily applies in a highly multivariate scenario.19
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